Identificador persistente para citar o vincular este elemento:
http://hdl.handle.net/10553/52008
| Título: | Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study | Autores/as: | Wägner, Ana María Sánchez-Quesada, Jose Luis Benítez, Sonia Bancells, Cristina Ordóñez-Llanos, Jordi Pérez, Antonio |
Clasificación UNESCO: | 320502 Endocrinología | Palabras clave: | Atorvastatin Gemfibrozil Inflammation Markers C-Reactive Protein Phospholipase A2 |
Fecha de publicación: | 2011 | Publicación seriada: | Diabetes Research and Clinical Practice | Resumen: | A randomized, crossover study compared the effects of atorvastatin, gemfibrozil and their combination on inflammatory markers in type 2 diabetes. C-reactive protein (CRP), lipoprotein-associated phospholipase A2 (Lp-PLA2), secretory phospholipase A2 (sPLA2), interleukin 8 (IL8), monocyte chemotactic protein 1 (MCP1) and tumor necrosis factor alpha (TNF alpha) were measured. Both lipid-lowering drugs had positive, complementary and additive effects on inflammatory markers, which were closely related to baseline inflammatory status. | URI: | http://hdl.handle.net/10553/52008 | ISSN: | 0168-8227 | DOI: | 10.1016/j.diabres.2011.03.009 | Fuente: | Diabetes Research and Clinical Practice [ISSN 0168-8227], v. 93 (1), p. E25-E28, (Julio 2011) |
| Colección: | Artículos |
Citas SCOPUSTM
14
actualizado el 14-abr-2024
Citas de WEB OF SCIENCETM
Citations
12
actualizado el 25-feb-2024
Visitas
69
actualizado el 10-feb-2024
Google ScholarTM
Verifica
Altmetric
Comparte
Exporta metadatos
Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.